Serious & Notifiable Infections — MCQs
On this page
A 42-year-old man from Kazakhstan presents with an 8-week history of cough, fever, and weight loss. Chest X-ray shows bilateral upper lobe cavitation. Sputum samples are sent for culture and molecular testing. GeneXpert MTB/RIF returns positive for Mycobacterium tuberculosis with rifampicin resistance detected. Culture subsequently confirms multidrug-resistant tuberculosis resistant to both rifampicin and isoniazid. Which regimen would be most appropriate for the initial intensive phase of treatment according to current WHO guidelines?
A 28-year-old woman at 32 weeks gestation is diagnosed with tuberculous meningitis. CSF analysis confirms the diagnosis and she requires urgent treatment. Regarding anti-tuberculosis therapy in this clinical scenario, which statement is most accurate?
A 52-year-old woman with newly diagnosed smear-positive pulmonary tuberculosis is started on rifampicin, isoniazid, pyrazinamide, and ethambutol. She has been taking warfarin for atrial fibrillation for the past 3 years with stable INR values between 2.0-3.0. Two weeks after starting anti-tuberculosis treatment, her INR is found to be 1.2. What is the most appropriate management of her anticoagulation?
A 3-year-old boy presents with a 2-week history of fever, irritability, and decreased activity. His parents report he has been refusing to walk for the past 3 days. On examination, he has neck stiffness, photophobia, and right-sided focal weakness. Lumbar puncture shows: opening pressure 28 cmH2O, glucose 1.8 mmol/L (serum glucose 5.2 mmol/L), protein 3.2 g/L, white cells 450/mm³ (70% lymphocytes). CT head shows basal meningeal enhancement and hydrocephalus. The most likely organism responsible for this presentation is:
A 64-year-old man with chronic obstructive pulmonary disease presents with a 4-week history of productive cough and weight loss. Chest X-ray shows upper lobe cavitation. Sputum microscopy reveals acid-fast bacilli. He is started on rifampicin, isoniazid, pyrazinamide, and ethambutol. After 2 weeks of treatment, he develops acute painful vision loss in his right eye with reduced visual acuity and red-green colour discrimination impairment. Which anti-tuberculosis medication is most likely responsible for his visual symptoms?
A 35-year-old woman is diagnosed with drug-sensitive pulmonary tuberculosis and started on rifampicin 600 mg, isoniazid 300 mg, pyrazinamide 1500 mg, and ethambutol 900 mg daily. She is also taking combined oral contraceptive pills. After 6 weeks, she presents with an unplanned pregnancy confirmed at 8 weeks gestation. What is the most appropriate modification to her tuberculosis treatment regimen?
According to UK guidelines, which of the following baseline investigations is mandatory before starting treatment for drug-sensitive pulmonary tuberculosis?
A 18-year-old university student presents to the emergency department with a 12-hour history of headache, fever, vomiting, and photophobia. Examination reveals fever of 39.1°C, neck stiffness, and a non-blanching petechial rash on the lower limbs. Blood pressure is 95/58 mmHg, heart rate 118 bpm. What is the most appropriate timing for administration of corticosteroids in this patient?
A 44-year-old man with newly diagnosed smear-positive pulmonary tuberculosis is commenced on rifampicin, isoniazid, pyrazinamide, and ethambutol. After 3 weeks of treatment, he develops painful, red, swollen joints affecting both knees and ankles. He also complains of burning pain in both feet. Blood tests show: uric acid 625 μmol/L, creatinine 110 μmol/L (baseline 98 μmol/L), ALT 45 U/L. Which anti-tuberculosis drug is most likely responsible for his joint symptoms?
What is the primary mechanism by which BCG vaccination provides protection against tuberculosis?
Serious & Notifiable Infections UK Medical PG Practice Questions and MCQs
Question 71: A 42-year-old man from Kazakhstan presents with an 8-week history of cough, fever, and weight loss. Chest X-ray shows bilateral upper lobe cavitation. Sputum samples are sent for culture and molecular testing. GeneXpert MTB/RIF returns positive for Mycobacterium tuberculosis with rifampicin resistance detected. Culture subsequently confirms multidrug-resistant tuberculosis resistant to both rifampicin and isoniazid. Which regimen would be most appropriate for the initial intensive phase of treatment according to current WHO guidelines?
- A. Rifampicin, isoniazid, pyrazinamide, ethambutol, and streptomycin
- B. Bedaquiline, linezolid, levofloxacin, cycloserine, and clofazimine (Correct Answer)
- C. Amoxicillin-clavulanate, imipenem, linezolid, and moxifloxacin
- D. Rifabutin, isoniazid, pyrazinamide, and levofloxacin
- E. Ethambutol, pyrazinamide, streptomycin, kanamycin, and para-aminosalicylic acid
Explanation: ***Bedaquiline, linezolid, levofloxacin, cycloserine, and clofazimine*** - Multidrug-resistant Tuberculosis (**MDR-TB**) is defined as resistance to at least **isoniazid** and **rifampicin**, requiring a shift to WHO Group A and B oral agents. - Current guidelines prioritize **Bedaquiline**, **Linezolid**, and a **Fluoroquinolone** (e.g., levofloxacin) as the core components of an all-oral, longer regimen to improve outcomes and reduce toxicity. *Rifampicin, isoniazid, pyrazinamide, ethambutol, and streptomycin* - This is the standard first-line therapy for **drug-susceptible TB**, which is ineffective here due to documented **rifampicin** and **isoniazid** resistance. - **Streptomycin** is no longer recommended as a primary agent due to high rates of resistance and significant **ototoxicity**. *Amoxicillin-clavulanate, imipenem, linezolid, and moxifloxacin* - While some of these drugs have activity, **amoxicillin-clavulanate** is not a recommended core anti-TB agent and has poor efficacy against *M. tuberculosis*. - **Imipenem** is typically reserved as a Group C (add-on) drug and requires intravenous administration, making it unsuitable for a standard initial MDR-TB oral regimen. *Rifabutin, isoniazid, pyrazinamide, and levofloxacin* - High-level **isoniazid** resistance usually renders the drug ineffective, and **rifabutin** typically exhibits complete **cross-resistance** in the presence of rifampicin resistance. - This regimen lacks a sufficient number of effective core agents (at least four) to achieve sterilization in MDR-TB. *Ethambutol, pyrazinamide, streptomycin, kanamycin, and para-aminosalicylic acid* - These agents represent older **injectable-based** therapeutic models that are no longer preferred due to high failure rates and severe **nephrotoxicity** or **hearing loss**. - Modern WHO guidelines have moved away from **Kanamycin** and **Streptomycin** in favor of more effective, less toxic **oral agents** like Bedaquiline.
Question 72: A 28-year-old woman at 32 weeks gestation is diagnosed with tuberculous meningitis. CSF analysis confirms the diagnosis and she requires urgent treatment. Regarding anti-tuberculosis therapy in this clinical scenario, which statement is most accurate?
- A. Streptomycin should be included in the initial regimen as it crosses the placenta well and is safe in pregnancy
- B. Pyrazinamide should be avoided throughout pregnancy due to teratogenic effects
- C. Standard four-drug therapy with rifampicin, isoniazid, pyrazinamide, and ethambutol can be used safely (Correct Answer)
- D. Ethambutol should be avoided after the first trimester due to risk of kernicterus
- E. Treatment should be delayed until after delivery to avoid fetal harm
Explanation: ***Standard four-drug therapy with rifampicin, isoniazid, pyrazinamide, and ethambutol can be used safely***- **Rifampicin**, **Isoniazid**, and **Ethambutol** are first-line agents considered safe in pregnancy, with **Pyridoxine (B6)** supplementation required to prevent isoniazid-induced peripheral neuropathy.- Guidelines from the **WHO** and other major bodies recommend this regimen for **tuberculous meningitis** in pregnancy as the benefits of treating this life-threatening condition significantly outweigh potential risks.*Streptomycin should be included in the initial regimen as it crosses the placenta well and is safe in pregnancy*- **Streptomycin** and other aminoglycosides are strictly **contraindicated** in pregnancy because they are known to cause **ototoxicity** and permanent **eighth cranial nerve damage** in the fetus.- While it may cross the placenta, its safety profile makes it unsuitable for standard obstetric tuberculosis management.*Pyrazinamide should be avoided throughout pregnancy due to teratogenic effects*- **Pyrazinamide** has no documented **teratogenic effects** in humans, and its use is now standard in many international guidelines for severe TB manifestations.- The drug is considered safe enough to be included in the intensive phase, especially in **meningitis** cases where it provides excellent **CSF penetration**.*Ethambutol should be avoided after the first trimester due to risk of kernicterus*- **Ethambutol** is not associated with **kernicterus**; that risk is primarily linked to medications like **sulfonamides** which displace bilirubin from albumin.- The primary safety concern with **Ethambutol** is **optic neuritis**, which is monitored in the mother but is not a contraindication for fetal safety.*Treatment should be delayed until after delivery to avoid fetal harm*- **Tuberculous meningitis** is a medical emergency with high **maternal and fetal mortality** rates if left untreated.- Delaying therapy would lead to irreversible neurological damage or death for the mother and severe complications or loss of the pregnancy.
Question 73: A 52-year-old woman with newly diagnosed smear-positive pulmonary tuberculosis is started on rifampicin, isoniazid, pyrazinamide, and ethambutol. She has been taking warfarin for atrial fibrillation for the past 3 years with stable INR values between 2.0-3.0. Two weeks after starting anti-tuberculosis treatment, her INR is found to be 1.2. What is the most appropriate management of her anticoagulation?
- A. Increase warfarin dose and monitor INR closely (Correct Answer)
- B. Switch warfarin to apixaban
- C. Add aspirin 75 mg daily and continue current warfarin dose
- D. Stop rifampicin and replace with levofloxacin
- E. Continue current warfarin dose and recheck INR in 4 weeks
Explanation: ***Increase warfarin dose and monitor INR closely***- **Rifampicin** is a potent inducer of hepatic **cytochrome P450 enzymes**, primarily CYP2C9, which significantly accelerates the metabolism of warfarin, leading to a subtherapeutic **INR** of 1.2.- To maintain therapeutic anticoagulation and prevent **thromboembolic events** like stroke in atrial fibrillation, the **warfarin dose** must be substantially increased with frequent **INR monitoring** until a new stable dose is achieved.*Switch warfarin to apixaban*- **Rifampicin** also induces P-glycoprotein and CYP3A4, which are involved in the metabolism of **DOACs** like apixaban, potentially reducing their efficacy and making them unreliable.- Unlike warfarin, **DOACs** cannot be easily titrated or monitored with a laboratory test like INR, making dose adjustment in the presence of a potent inducer challenging and potentially unsafe.*Add aspirin 75 mg daily and continue current warfarin dose*- **Aspirin** is an antiplatelet agent and provides insufficient antithrombotic protection against stroke in **atrial fibrillation** compared to therapeutic anticoagulation with warfarin.- Adding aspirin increases the **risk of bleeding** without correcting the underlying subtherapeutic anticoagulation caused by the rifampicin-warfarin interaction.*Stop rifampicin and replace with levofloxacin*- **Rifampicin** is a cornerstone of first-line **tuberculosis treatment**; stopping it unnecessarily could lead to treatment failure and development of **drug-resistant TB**.- Management should focus on addressing the drug-drug interaction by adjusting the **warfarin dose**, rather than compromising the highly effective and essential anti-tuberculosis regimen.*Continue current warfarin dose and recheck INR in 4 weeks*- An **INR of 1.2** in a patient with **atrial fibrillation** indicates a dangerously subtherapeutic level, placing her at an immediate and high risk for **embolic stroke**.- Delaying dose adjustment for four weeks is unacceptable and unsafe given the established **enzyme induction** by rifampicin and the critical need for therapeutic anticoagulation.
Question 74: A 3-year-old boy presents with a 2-week history of fever, irritability, and decreased activity. His parents report he has been refusing to walk for the past 3 days. On examination, he has neck stiffness, photophobia, and right-sided focal weakness. Lumbar puncture shows: opening pressure 28 cmH2O, glucose 1.8 mmol/L (serum glucose 5.2 mmol/L), protein 3.2 g/L, white cells 450/mm³ (70% lymphocytes). CT head shows basal meningeal enhancement and hydrocephalus. The most likely organism responsible for this presentation is:
- A. Mycobacterium tuberculosis (Correct Answer)
- B. Neisseria meningitidis
- C. Streptococcus pneumoniae
- D. Haemophilus influenzae type b
- E. Listeria monocytogenes
Explanation: ***Mycobacterium tuberculosis*** - The subacute presentation over 2 weeks, **lymphocytic pleocytosis**, markedly **elevated protein**, and **low glucose** in the CSF are classic hallmarks of tuberculous meningitis. - Key neuroimaging findings of **basal meningeal enhancement** and **hydrocephalus**, combined with focal neurological deficits from **vasculitis**, are highly specific for this diagnosis. *Neisseria meningitidis* - Typically presents acutely over hours to days with high fever, a **petechial or purpuric rash**, and rapid clinical deterioration. - CSF analysis in bacterial meningitis usually shows a **neutrophilic predominance** rather than the lymphocytic shift seen here. *Streptococcus pneumoniae* - This is the most common cause of bacterial meningitis in children but presents with an **acute onset** and significantly higher **white cell counts** with neutrophilia. - While it can cause complications, it does not typically produce the **basal exudates** or the prolonged 2-week prodrome characteristic of TB. *Haemophilus influenzae type b* - Incidence has significantly decreased due to **Hib vaccination**, and it usually presents as an **acute pyogenic meningitis**. - It lacks the characteristic **subacute progression** and specific **basal cistern involvement** seen in this patient's CT scan. *Listeria monocytogenes* - Usually affects **neonates**, the elderly, or **immunocompromised individuals**, making it an unlikely cause for a healthy 3-year-old. - While it can cause a subacute picture (rhombencephalitis), it does not typically present with the extensive **basal enhancement** and hydrocephalus seen in tuberculous meningitis.
Question 75: A 64-year-old man with chronic obstructive pulmonary disease presents with a 4-week history of productive cough and weight loss. Chest X-ray shows upper lobe cavitation. Sputum microscopy reveals acid-fast bacilli. He is started on rifampicin, isoniazid, pyrazinamide, and ethambutol. After 2 weeks of treatment, he develops acute painful vision loss in his right eye with reduced visual acuity and red-green colour discrimination impairment. Which anti-tuberculosis medication is most likely responsible for his visual symptoms?
- A. Ethambutol (Correct Answer)
- B. Isoniazid
- C. Pyrazinamide
- D. Rifampicin
- E. Streptomycin
Explanation: ***Ethambutol*** - This medication is classically associated with **optic neuritis**, leading to reduced **visual acuity**, central scotomas, and a characteristic loss of **red-green colour discrimination**. - The toxicity is typically **dose-dependent** and requires immediate discontinuation of the drug to prevent permanent visual impairment. *Isoniazid* - Primarily known for causing **peripheral neuropathy** due to competitive inhibition of **pyridoxine (vitamin B6)**. - It is also frequently associated with **hepatotoxicity** (elevated liver enzymes) rather than direct visual pathway damage. *Pyrazinamide* - The most common side effects are **hyperuricemia**, which can precipitate acute **gouty arthritis**, and hepatotoxicity. - It does not have any documented association with **optic nerve** damage or visual acuity changes. *Rifampicin* - Known for causing a benign **orange discoloration** of body fluids, including urine, sweat, and tears. - While it can be hepatotoxic and induce **cytochrome P450**, it does not cause acute painful **vision loss**. *Streptomycin* - This aminoglycoside is primarily associated with **ototoxicity**, leading to hearing loss or **vestibular dysfunction** (vertigo/tinnitus). - It is also known for **nephrotoxicity**, but it does not affect **color vision** or the optic nerve.
Question 76: A 35-year-old woman is diagnosed with drug-sensitive pulmonary tuberculosis and started on rifampicin 600 mg, isoniazid 300 mg, pyrazinamide 1500 mg, and ethambutol 900 mg daily. She is also taking combined oral contraceptive pills. After 6 weeks, she presents with an unplanned pregnancy confirmed at 8 weeks gestation. What is the most appropriate modification to her tuberculosis treatment regimen?
- A. Stop ethambutol and pyrazinamide, continue rifampicin and isoniazid only
- B. Stop all tuberculosis drugs until after delivery to avoid teratogenic effects
- C. Continue current four-drug regimen unchanged and add pyridoxine supplementation (Correct Answer)
- D. Replace rifampicin with moxifloxacin due to concerns about fetal safety
- E. Continue rifampicin and isoniazid only, stop pyrazinamide and ethambutol
Explanation: ***Continue current four-drug regimen unchanged and add pyridoxine supplementation*** - First-line anti-tuberculosis drugs (**Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol**) are considered safe in pregnancy, and untreated tuberculosis poses a greater risk to the fetus than the medications. - **Pyridoxine (Vitamin B6)** must be added to prevent **isoniazid-induced peripheral neuropathy**, as the requirement for B6 is increased during pregnancy. *Stop ethambutol and pyrazinamide, continue rifampicin and isoniazid only* - Standard TB treatment requires an intensive phase of four drugs to prevent the development of **drug resistance** and ensure the sterilization of lesions. - Reducing the number of agents without clinical indication (like drug-induced hepatitis) increases the risk of **treatment failure** and persistent infection. *Stop all tuberculosis drugs until after delivery to avoid teratogenic effects* - Untreated pulmonary tuberculosis is associated with significantly increased rates of **spontaneous abortion**, low birth weight, and **congenital tuberculosis**. - First-line anti-TB medications are not classified as significantly **teratogenic**; therefore, the benefits of maternal treatment far outweigh the risks. *Replace rifampicin with moxifloxacin due to concerns about fetal safety* - **Fluoroquinolones** like moxifloxacin are generally avoided in pregnancy due to concerns regarding **fetal cartilage toxicity** observed in animal studies. - Rifampicin is a cornerstone of therapy and is safe for the fetus, though maternal use requires **Vitamin K** supplementation for the neonate at birth to prevent hemorrhagic disease. *Continue rifampicin and isoniazid only, stop pyrazinamide and ethambutol* - This approach is incorrect for the **intensive phase** of treatment (first 2 months), where all four drugs are necessary to kill rapidly dividing bacilli. - While pyrazinamide was historically avoided due to limited data, modern international guidelines (WHO) confirm it is **safe and effective** for use during pregnancy.
Question 77: According to UK guidelines, which of the following baseline investigations is mandatory before starting treatment for drug-sensitive pulmonary tuberculosis?
- A. Visual acuity and colour vision testing using Ishihara charts (Correct Answer)
- B. Audiometry to establish baseline hearing thresholds
- C. Electrocardiogram to assess QTc interval
- D. Chest CT scan to assess extent of parenchymal disease
- E. Full blood count, renal function, and liver function tests
Explanation: ***Visual acuity and colour vision testing using Ishihara charts*** - Mandatory baseline testing is required because **ethambutol** can cause dose-related **optic neuritis**, which may lead to irreversible visual loss. - Establishing a baseline for **visual acuity** and **red-green color discrimination** allows for early detection and comparison if visual side effects occur during treatment. *Audiometry to establish baseline hearing thresholds* - Baseline hearing tests are essential when using **aminoglycosides** (like streptomycin or amikacin), which are **ototoxic**. - Audiometry is not a mandatory baseline investigation for the standard drug-sensitive regimen of **rifampicin, isoniazid, pyrazinamide, and ethambutol**. *Electrocardiogram to assess QTc interval* - ECG monitoring for **QTc prolongation** is necessary when using certain second-line MDR-TB drugs or **fluoroquinolones** (e.g., moxifloxacin). - Standard first-line pulmonary tuberculosis treatment does not typically mandate an ECG unless there is significant **electrolyte imbalance** or pre-existing cardiac risk. *Chest CT scan to assess extent of parenchymal disease* - A **chest X-ray** is the standard radiological investigation for diagnosis and monitoring; a **CT scan** is not routinely mandatory. - CT scans are generally reserved for clarifying diagnostic uncertainties or screening for complications like **bronchiectasis** or **cavitation** not seen on X-ray. *Full blood count, renal function, and liver function tests* - While these are recommended to monitor for **hepatotoxicity** (isoniazid, rifampicin, pyrazinamide) and manage drug dosing, the question asks for the specific mandatory test related to drug-specific toxicity unique to the first-line regimen's safety profile. - **Liver function tests (LFTs)** are crucial, but **visual assessment** is the unique mandatory sensory baseline required before the administration of **ethambutol**.
Question 78: A 18-year-old university student presents to the emergency department with a 12-hour history of headache, fever, vomiting, and photophobia. Examination reveals fever of 39.1°C, neck stiffness, and a non-blanching petechial rash on the lower limbs. Blood pressure is 95/58 mmHg, heart rate 118 bpm. What is the most appropriate timing for administration of corticosteroids in this patient?
- A. Immediately, before or with the first dose of antibiotics
- B. After lumbar puncture confirms bacterial meningitis
- C. Only if CSF Gram stain shows Gram-positive organisms
- D. Corticosteroids are contraindicated due to hypotension and possible septic shock (Correct Answer)
- E. After 24 hours of antibiotics if clinical improvement is not seen
Explanation: ***Corticosteroids are contraindicated due to hypotension and possible septic shock*** - The patient presents with a **non-blanching petechial rash** and **hypotension** (95/58 mmHg), indicating **meningococcal septicaemia** and septic shock. - Clinical guidelines state that **dexamethasone** should be avoided in cases of suspected **meningococcal septicaemia** or when the patient is in **septic shock**, as it may worsen outcomes. *Immediately, before or with the first dose of antibiotics* - While this is the standard timing for **bacterial meningitis** to reduce neurological sequelae, it is withheld here due to signs of **circulatory collapse**. - Administering steroids during **septic shock** is generally not recommended in the initial management of suspected meningitis with a rash. *After lumbar puncture confirms bacterial meningitis* - Steroids should be given **before or with** the first dose of antibiotics; waiting for **lumbar puncture** results causes a delay that increases morbidity. - In this specific case, **meningococcal septicaemia** is already suspected clinically, making steroids inappropriate regardless of the LP results. *Only if CSF Gram stain shows Gram-positive organisms* - This approach targets **Streptococcus pneumoniae**, where steroids provide the most benefit, but the decision to start or withhold them is made **before** Gram stain results are available. - The priority in this patient is managing **sepsis** and **haemodynamic instability** rather than targeted steroid therapy for Gram-positive organisms. *After 24 hours of antibiotics if clinical improvement is not seen* - **Corticosteroids** do not provide the desired anti-inflammatory benefit if started more than **12 hours** after the first dose of antibiotics. - Delayed administration has no proven benefit in reducing the **neurological complications** of acute bacterial meningitis.
Question 79: A 44-year-old man with newly diagnosed smear-positive pulmonary tuberculosis is commenced on rifampicin, isoniazid, pyrazinamide, and ethambutol. After 3 weeks of treatment, he develops painful, red, swollen joints affecting both knees and ankles. He also complains of burning pain in both feet. Blood tests show: uric acid 625 μmol/L, creatinine 110 μmol/L (baseline 98 μmol/L), ALT 45 U/L. Which anti-tuberculosis drug is most likely responsible for his joint symptoms?
- A. Rifampicin
- B. Isoniazid
- C. Pyrazinamide (Correct Answer)
- D. Ethambutol
- E. The combination of rifampicin and isoniazid
Explanation: ***Pyrazinamide*** - **Pyrazinamide** inhibits the renal tubular secretion of **uric acid**, leading to **hyperuricaemia** and frequently causing arthralgia or acute **gouty arthritis**. - The patient's serum **uric acid level of 625 μmol/L** and involvement of large joints like the knees and ankles are classic manifestations of pyrazinamide-induced joint symptoms. *Rifampicin* - Key side effects include **orange-colored body fluids**, hepatitis, and a flu-like syndrome, but it is not directly linked to **hyperuricaemia**. - While it can cause general arthralgia, it does not typically present as acute, swollen joint **arthritis** like gout. *Isoniazid* - This drug is primarily associated with **peripheral neuropathy** (burning pain in the feet) due to **pyridoxine (Vitamin B6)** depletion, which this patient also displays. - It does not significantly affect **uric acid levels** or cause the red, swollen joints characteristic of inflammatory arthritis. *Ethambutol* - The most significant toxic effect of ethambutol is **optic neuritis**, necessitating regular visual acuity and color vision monitoring. - Although it may moderately increase serum urate, **Pyrazinamide** is much more potently associated with clinical **hyperuricaemic arthritis**. *The combination of rifampicin and isoniazid* - This combination is notorious for causing **drug-induced hepatitis**, evidenced by elevated **ALT** and bilirubin, rather than joint pathology. - Their combined effect does not explain the specific biochemical finding of **elevated uric acid** and the resulting acute arthritic symptoms.
Question 80: What is the primary mechanism by which BCG vaccination provides protection against tuberculosis?
- A. Production of neutralizing antibodies against mycobacterial surface antigens
- B. Direct killing of Mycobacterium tuberculosis by vaccine-derived antibodies
- C. Stimulation of cell-mediated immunity through T-lymphocyte activation (Correct Answer)
- D. Enhancement of complement-mediated lysis of mycobacteria
- E. Induction of trained immunity in natural killer cells
Explanation: ***Stimulation of cell-mediated immunity through T-lymphocyte activation*** - BCG is a live attenuated vaccine that triggers a **Th1-mediated response**, activating **CD4+ and CD8+ T-cells** to recognize mycobacterial antigens. - These activated T-cells produce **interferon-gamma (IFN-γ)**, which enhances the ability of **macrophages** to kill intracellular Mycobacterium tuberculosis. *Production of neutralizing antibodies against mycobacterial surface antigens* - Mycobacterium tuberculosis is an **intracellular pathogen**, primarily residing within cells where antibodies have limited access and effectiveness. - While **humoral immunity** (antibodies) is induced by many vaccines, it does not provide primary or effective protection against tuberculosis. *Direct killing of Mycobacterium tuberculosis by vaccine-derived antibodies* - Protection against TB primarily relies on the **cellular arm** of the immune system, specifically T-cells and activated macrophages, rather than direct antibody-mediated killing. - Antibody-mediated killing is largely ineffective because the bacteria survive and replicate inside **phagosomes** of macrophages, protected from extracellular antibodies. *Enhancement of complement-mediated lysis of mycobacteria* - The **waxy cell wall (mycolic acids)** of mycobacteria provides significant resistance to complement-mediated lysis and other innate immune defenses. - **Complement activation** is not a primary or effective mechanism for the clearance or control of Mycobacterium tuberculosis infection. *Induction of trained immunity in natural killer cells* - While BCG is known to induce **trained immunity** via epigenetic reprogramming of innate cells, providing broader non-specific protection, this is a secondary effect. - The specific, primary mechanism of targeted protection against M. tuberculosis itself remains the activation of the **adaptive cell-mediated immune system**.
Practice by Chapter
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free